Changes in Lifestyle Habits in Individuals with Diabetes during the COVID-19 Pandemic: The ELSA-Brasil Cohort Study
The COVID-19 pandemic and society’s response to it may have constrained the ability of those with diabetes to achieve a healthy lifestyle.
Scientific Papers
News
Article
Effectiveness of community-based oral antiviral treatments against severe COVID-19 outcomes in people 70 years and over in Victoria, Australia, 2022: an observational study
Oral Antiviral (OAV) COVID-19 treatments are widely used, but evidence for their effectiveness against the Omicron variant in higher risk, vaccinated individuals is limited.
Scientific Papers
Article
News
Factors associated with delayed diagnosis of symptomatic adult COVID-19 cases presenting to primary care: a population-wide study during transition from Delta to Omicron BA.1 in Singapore
During pandemics, avoiding time delay in diagnosing infection is crucial.
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
Is influenza B/Yamagata extinct and what public health implications could this have? An updated literature review and comprehensive assessment of global surveillance databases
Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan
CD8+ T cells provide robust antiviral immunity, but how epitope-specific T cells evolve across the human lifespan is unclear.
|
9th Influenza Conference 2023
Increasing Influenza vaccination uptake among children aged 2-17 years old in Ireland: A new initiative deployed mid-season
POSTER 436 from #ESWI2023
|
9th Influenza Conference 2023
Studying the impact of NS1 on host tropism of influenza A virus
POSTER 632 from #ESWI2023
|
9th Influenza Conference 2023
Neuraminidase-dependent entry of influenza A virus is determined by haemagglutinin receptor- binding activity
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males
|
9th Influenza Conference 2023
Novel Approach For An Evolution-Proof Influenza Vaccine
POSTER 403 from #ESWI2023